Duly Health Brings Genetic-Based Weight Loss Treatment to Chicago with MyPhenome Test

Chicago-area patients now have access to precision medicine for obesity care with genetic obesity test from Phenomix Sciences.

, /PRNewswire/ -- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that uses data intelligence to treat obesity, today announces its MyPhenome™ test is now available at Duly Health and Care's Weight Loss Clinics in Naperville, Westmont, and Oak Brook, Ill. Under the leadership of obesity management expert, Zaid Jabbar, M.D., M.S., the launch provides Chicago-area patients with a groundbreaking tool to personalize obesity treatment based on their unique biology and genetic profile.

As more than 61% of adults in the Chicago metropolitan area are overweight or obese, the demand for effective weight loss treatments continues to grow. Named a TIME Best Invention of 2024, the MyPhenome test is a simple saliva swab that identifies the biological factors, or phenotypes, that cause obesity and helps physicians personalize treatments for more effective weight loss. Studies have shown obesity treatments tailored to a patient's biological traits, identified through the MyPhenome test, are twice as effective as other one-size-fits-all treatments.

"For so many people struggling with obesity or weight gain, they're often left feeling like they lack the willpower, but in reality, the answer is in their biology," said Dr. Jabbar. "The MyPhenome test helps uncover the underlying biological factors contributing to obesity, allowing us to move beyond trial-and-error treatments and create truly personalized care plans that give patients the best chance for long-term success."

Along with the phenotype results, patients receive a comprehensive MyPhenome test report with insights into their individual biology and the root causes of their obesity. Healthcare providers use this information to develop customized treatment plans, including lifestyle and diet interventions as well as medication and/or procedure recommendations. The MyPhenome patient portal offers ongoing weight loss resources like meal plans and recipes that complement their phenotype(s).

"The MyPhenome test is a game-changer in obesity care," said Liv Williamsen, Chief Operating Officer of Phenomix Sciences. "Physicians like Dr. Jabbar now have a powerful tool to move beyond trial-and-error treatments and provide targeted and data-driven care. We're thrilled to bring this tool to the Chicago area and help patients feel understood and supported in their weight loss journey."

To schedule a MyPhenome test through Duly Health, click here or call 630-348-3840.

For more information on the MyPhenome test or for out-of-network patients, click here to find a test provider near you.

About Phenomix Sciences
Phenomix Sciences is a biotechnology pioneer on a mission to conquer obesity globally through the science of phenotyping, the understanding of how genes combined with environmental and behavioral factors can inform obesity treatment plans. Mayo Clinic physicians, scientists, and researchers, Drs. Acosta and Camilleri, founded the company under the belief that the key to understanding obesity is unprecedented access to its clinical and molecular information throughout all stages and phenotypes of the disease. Phenomix leverages data intelligence to yield better accuracy in predicting individual patient responses to specific weight loss interventions and reducing the variability in weight loss results for patients. For more information, please visit www.phenomixsciences.com.

About Duly Health and Care:
The Duly Health and Care brand consists of some of the largest independent, multi-specialty, physician-directed medical groups in the nation, with more than 1,000 primary care and specialty care providers and over 6,000 team members across more than 150 locations. The Duly Health and Care brand includes three medical groups – DuPage Medical Group, Ltd., Quincy Medical Group, and The South Bend Clinic, LLC. Duly is deeply committed to caring for patients in traditional and value-based care arrangements, ensuring a focus on quality, efficiency, and enhanced patient experiences throughout the Midwest.

For more information, visit www.dulyhealthandcare.com.

Media Contact:
[email protected] 

SOURCE Phenomix Sciences